Journal ArticleAm J Transplant · July 16, 2024
Mycoplasma hominis and Ureaplasma species are urogenital mollicutes that can cause serious donor-derived infections in lung transplant recipients. Best practices for mollicute screening remain unknown. We conducted a single-center prospective study analyzi ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 12, 2024
We identified 23 cases of Mycobacterium immunogenum respiratory acquisition linked to a colonized plumbing system at a new hospital addition. We conducted a genomic and epidemiologic investigation to assess for clonal acquisition of M. immunogenum from hos ...
Full textLink to itemCite
Journal ArticleJ Pharm Pract · June 2024
Background: Cytomegalovirus (CMV) infection after abdominal organ transplantation is associated with increased morbidity and mortality. The use of valganciclovir for CMV prophylaxis is limited by drug-induced myelosuppression and potential emergence of res ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · May 24, 2024
This study identified 26 late invasive primary surgical site infection (IP-SSI) within 4-12 months of transplantation among 2073 SOT recipients at Duke University Hospital over the period 2015-2019. Thoracic organ transplants accounted for 25 late IP-SSI. ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2024
Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective ...
Full textOpen AccessLink to itemCite
Journal ArticleAntimicrob Agents Chemother · March 6, 2024
Invasive primary Candida surgical site infections (IP-SSIs) are a common complication of liver transplantation, and targeted antifungal prophylaxis is an efficient strategy to limit their occurrence. We performed a retrospective single-center cohort study ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · February 2024
BACKGROUND: Many centers use universal antifungal prophylaxis after lung transplant, but risk factors for invasive fungal infection (IFI) in this setting are poorly described. METHODS: This retrospective, single-center cohort study including 603 lung trans ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · November 21, 2023
The rapid pace of name changes of medically important fungi is creating challenges for clinical laboratories and clinicians involved in patient care. We describe two sources of name change which have different drivers, at the species versus the genus level ...
Full textLink to itemCite
Journal ArticleTransplant Direct · November 2023
BACKGROUND: Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)-positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipients with ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2023
BACKGROUND: Antifungal prophylaxis can prevent invasive fungal diseases (IFDs) in high-risk, immunocompromised patients. This study assessed the real-world use of mold-active triazoles (MATs) for the prevention of IFDs. METHODS: This subgroup analysis of a ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr · August 2023
OBJECTIVE: To characterize the relationships between social determinants of health (SDOH) and outcomes for children born extremely preterm. STUDY DESIGN: This is a cohort study of infants born at 22-26 weeks of gestation in National Institute of Child Heal ...
Full textLink to itemCite
Journal ArticleAm J Transplant · July 2023
Nontuberculous mycobacteria are emerging pathogens, yet data on the epidemiology and management of extrapulmonary nontuberculous mycobacteria infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We ...
Full textLink to itemCite
Journal ArticleCell · June 22, 2023
Systemic candidiasis is a common, high-mortality, nosocomial fungal infection. Unexpectedly, it has emerged as a complication of anti-complement C5-targeted monoclonal antibody treatment, indicating a critical niche for C5 in antifungal immunity. We identi ...
Full textLink to itemCite
Journal ArticleLancet · January 7, 2023
BACKGROUND: Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp after bloo ...
Full textLink to itemCite
Journal ArticleAm J Transplant · December 2022
Surgical site infections (SSI) are severe complications of solid organ transplant (SOT). This retrospective study assessed the epidemiology of and outcomes associated with invasive primary SSI (IP-SSI) occurring within 3 months of transplantation in adult ...
Full textOpen AccessLink to itemCite
Journal ArticleMycoses · November 2022
BACKGROUND AND OBJECTIVES: Patients undergoing induction/reinduction chemotherapy for haematologic malignancies (HM) are at risk for invasive fungal infections (IFIs). In 2015, Duke University Hospital (DUH) implemented a new standardised fungal prophylaxi ...
Full textLink to itemCite
Journal ArticleJ Fungi (Basel) · October 25, 2022
Molds are ubiquitous in the environment, and immunocompromised patients are at substantial risk of morbidity and mortality due to their underlying disease and the resistance of pathogenic molds to currently recommended antifungal therapies. This combinatio ...
Full textLink to itemCite
Journal ArticleAm J Transplant · July 16, 2024
Mycoplasma hominis and Ureaplasma species are urogenital mollicutes that can cause serious donor-derived infections in lung transplant recipients. Best practices for mollicute screening remain unknown. We conducted a single-center prospective study analyzi ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 12, 2024
We identified 23 cases of Mycobacterium immunogenum respiratory acquisition linked to a colonized plumbing system at a new hospital addition. We conducted a genomic and epidemiologic investigation to assess for clonal acquisition of M. immunogenum from hos ...
Full textLink to itemCite
Journal ArticleJ Pharm Pract · June 2024
Background: Cytomegalovirus (CMV) infection after abdominal organ transplantation is associated with increased morbidity and mortality. The use of valganciclovir for CMV prophylaxis is limited by drug-induced myelosuppression and potential emergence of res ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · May 24, 2024
This study identified 26 late invasive primary surgical site infection (IP-SSI) within 4-12 months of transplantation among 2073 SOT recipients at Duke University Hospital over the period 2015-2019. Thoracic organ transplants accounted for 25 late IP-SSI. ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2024
Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective ...
Full textOpen AccessLink to itemCite
Journal ArticleAntimicrob Agents Chemother · March 6, 2024
Invasive primary Candida surgical site infections (IP-SSIs) are a common complication of liver transplantation, and targeted antifungal prophylaxis is an efficient strategy to limit their occurrence. We performed a retrospective single-center cohort study ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · February 2024
BACKGROUND: Many centers use universal antifungal prophylaxis after lung transplant, but risk factors for invasive fungal infection (IFI) in this setting are poorly described. METHODS: This retrospective, single-center cohort study including 603 lung trans ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · November 21, 2023
The rapid pace of name changes of medically important fungi is creating challenges for clinical laboratories and clinicians involved in patient care. We describe two sources of name change which have different drivers, at the species versus the genus level ...
Full textLink to itemCite
Journal ArticleTransplant Direct · November 2023
BACKGROUND: Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)-positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipients with ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2023
BACKGROUND: Antifungal prophylaxis can prevent invasive fungal diseases (IFDs) in high-risk, immunocompromised patients. This study assessed the real-world use of mold-active triazoles (MATs) for the prevention of IFDs. METHODS: This subgroup analysis of a ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr · August 2023
OBJECTIVE: To characterize the relationships between social determinants of health (SDOH) and outcomes for children born extremely preterm. STUDY DESIGN: This is a cohort study of infants born at 22-26 weeks of gestation in National Institute of Child Heal ...
Full textLink to itemCite
Journal ArticleAm J Transplant · July 2023
Nontuberculous mycobacteria are emerging pathogens, yet data on the epidemiology and management of extrapulmonary nontuberculous mycobacteria infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We ...
Full textLink to itemCite
Journal ArticleCell · June 22, 2023
Systemic candidiasis is a common, high-mortality, nosocomial fungal infection. Unexpectedly, it has emerged as a complication of anti-complement C5-targeted monoclonal antibody treatment, indicating a critical niche for C5 in antifungal immunity. We identi ...
Full textLink to itemCite
Journal ArticleLancet · January 7, 2023
BACKGROUND: Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp after bloo ...
Full textLink to itemCite
Journal ArticleAm J Transplant · December 2022
Surgical site infections (SSI) are severe complications of solid organ transplant (SOT). This retrospective study assessed the epidemiology of and outcomes associated with invasive primary SSI (IP-SSI) occurring within 3 months of transplantation in adult ...
Full textOpen AccessLink to itemCite
Journal ArticleMycoses · November 2022
BACKGROUND AND OBJECTIVES: Patients undergoing induction/reinduction chemotherapy for haematologic malignancies (HM) are at risk for invasive fungal infections (IFIs). In 2015, Duke University Hospital (DUH) implemented a new standardised fungal prophylaxi ...
Full textLink to itemCite
Journal ArticleJ Fungi (Basel) · October 25, 2022
Molds are ubiquitous in the environment, and immunocompromised patients are at substantial risk of morbidity and mortality due to their underlying disease and the resistance of pathogenic molds to currently recommended antifungal therapies. This combinatio ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 10, 2022
BACKGROUND: Therapies for refractory cytomegalovirus infections (with or without resistance [R/R]) in transplant recipients are limited by toxicities. Maribavir has multimodal anti-cytomegalovirus activity through the inhibition of UL97 protein kinase. MET ...
Full textOpen AccessLink to itemCite
Journal ArticleInfect Dis Ther · August 2022
INTRODUCTION: 'Real-world' data for mold-active triazoles (MATs) in the treatment of invasive fungal infections (IFIs) are lacking. This study evaluated usage of MATs in a disease registry for the management of IFIs. METHODS: Data were collected for this m ...
Full textOpen AccessLink to itemCite
Journal ArticleAntimicrob Agents Chemother · June 21, 2022
Inhaled formulations of amphotericin B are the most widely used antifungal prophylactic agents in lung transplant recipients, yet there are limited data on their safety. We performed a single-center retrospective cohort study of 603 consecutive patients wh ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · February 25, 2022
INTRODUCTION: Most studies of solid organ transplant (SOT) recipients with COVID-19 focus on outcomes within one month of illness onset. Delayed mortality in SOT recipients hospitalized for COVID-19 has not been fully examined. METHODS: We used data from a ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Transplant · January 2022
Mortality among patients hospitalized for COVID-19 has declined over the course of the pandemic. Mortality trends specifically in solid organ transplant recipients (SOTR) are unknown. Using data from a multicenter registry of SOTR hospitalized for COVID-19 ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · November 2021
We report the first case of Curvularia alcornii aortic pseudoaneurysm following bioprosthetic aortic valve replacement in an immunocompetent host. Infection was complicated by septic emboli to multiple organs. Despite aggressive surgical intervention and a ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · October 2021
BACKGROUND: Consensus definitions for the diagnosis of invasive fungal diseases (IFDs) were updated in 2020 to increase the certainty of IFD for inclusion in clinical trials, for instance by increasing biomarker cutoff limits to define positivity. To date, ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Transplant · August 2021
Lung transplant recipients (LTR) with coronavirus disease 2019 (COVID-19) may have higher mortality than non-lung solid organ transplant recipients (SOTR), but direct comparisons are limited. Risk factors for mortality specifically in LTR have not been exp ...
Full textLink to itemCite
Journal ArticleGenome Med · July 5, 2021
BACKGROUND: Candidemia is one of the most common nosocomial bloodstream infections in the United States, causing significant morbidity and mortality in hospitalized patients, but the breadth of the host response to Candida infections in human patients rema ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Transplant · June 2021
We undertook a prospective, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and cytokine response in transplant recipients to immunocomp ...
Full textOpen AccessLink to itemCite
Journal ArticleArch Dis Child Fetal Neonatal Ed · May 2021
OBJECTIVE: To identify sociodemographic and clinical factors associated with withholding or withdrawing life-sustaining treatment (WWLST) for extremely low gestational age neonates. DESIGN: Observational study of prospectively collected registry data from ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 8, 2021
BACKGROUND: We recently mitigated a clonal outbreak of hospital-acquired Mycobacterium abscessus complex (MABC), which included a large cluster of adult patients who developed invasive infection after exposure to heater-cooler units during cardiac surgery. ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · March 12, 2021
BACKGROUND: Clinical imaging in suspected invasive fungal disease (IFD) has a significant role in early detection of disease and helps direct further testing and treatment. Revised definitions of IFD from the EORTC/MSGERC were recently published and provid ...
Full textLink to itemCite
Journal ArticleJ Infect · November 2020
OBJECTIVES: Emerging invasive fungal infections (IFI) have become a notable challenge. Apart from the more frequently described fusariosis, lomentosporiosis, mucormycosis, scedosporiosis, and certain dematiaceae or yeasts, little is known about extremely r ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Infect Dis · September 14, 2020
Opportunities for leadership in the specialty of infectious diseases (ID) have markedly increased over the last decade, including in newly recognized areas. Commensurate with the expansion of opportunities in ID, pathways to leadership positions within the ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 12, 2020
BACKGROUND: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have be ...
Full textOpen AccessLink to itemCite
Journal ArticleTransplantation · June 2020
BACKGROUND: Respiratory syncytial virus (RSV) infection in lung transplant recipients (LTRs) causes mortality rates of 10%-20% despite antiviral therapy. Ribavirin (RBV) has been used to treat RSV-infected LTRs with limited data. METHODS: A retrospective s ...
Full textLink to itemCite
Journal ArticleBiol Blood Marrow Transplant · March 2020
Cytomegalovirus (CMV) results in significant morbidity and mortality following hematopoietic cell transplantation (HCT). Establishing the cost and clinical impact is imperative to the selection of appropriate CMV preventative strategies. This is a retrospe ...
Full textLink to itemCite
Journal ArticleEur J Clin Microbiol Infect Dis · March 2020
Evaluate risk factors for cytomegalovirus (CMV) reactivation during the first year after kidney transplantation in the CMV-seropositive older recipient. Retrospective single-center study. Between 2011 and 2015, 91 patients ≥ 65 years received a kidney tran ...
Full textLink to itemCite
Journal ArticleMycoses · March 2020
BACKGROUND: The new Rasamsonia spp. complex can develop invasive infection in immunosuppression or chronic pulmonary disease. It has potential to be misidentified as other genera due to morphological similarities. Nowadays, there is a gap of knowledge on t ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 1, 2020
BACKGROUND: Lung transplant recipients commonly develop invasive fungal infections (IFIs), but the most effective strategies to prevent IFIs following lung transplantation are not known. METHODS: We prospectively collected clinical data on all patients who ...
Full textLink to itemCite
Journal ArticleJ Pediatr · December 2019
OBJECTIVE: To evaluate neurodevelopmental outcomes of preterm infants with need for Child Protective Services (CPS) supervision at hospital discharge compared with those discharged without CPS supervision. STUDY DESIGN: For infants born at <27 weeks of ges ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · November 27, 2019
In October 2018, the Infectious Diseases Society of America (IDSA) Board of Directors (BOD) decided to develop a 2019 IDSA Strategic Plan. The IDSA BOD has invested in strategic planning at regular intervals as part of an ongoing process to review and to r ...
Full textLink to itemCite
Journal ArticleJ Pediatr · June 2019
OBJECTIVE: To determine the impact of policy changes for pulse oximetry oxygen saturation (SpO2) alarm limits on neonatal mortality and morbidity among infants born very preterm. STUDY DESIGN: This was a retrospective cohort study of infants born very pret ...
Full textLink to itemCite
Journal ArticleJ Pediatr · May 2019
OBJECTIVE: To determine patterns of respiratory medications used in neonatal intensive care unit graduates. STUDY DESIGN: The Prematurity Respiratory Outcomes Program enrolled 835 babies <29 weeks of gestation in the first week. Of 751 survivors, 738 (98%) ...
Full textLink to itemCite
Journal ArticleClin Transplant · April 2019
Infections threaten successful outcomes after kidney transplantation. Our aim was to determine if the number, types of infections and the risk factors for common infections differed between older compared to younger kidney transplant (KT) recipients in the ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 7, 2019
BACKGROUND: Clostridium difficile-associated diarrhea (CDAD) is common during hematopoietic stem-cell transplantation (HSCT) and is associated with increased morbidity and mortality. We evaluated fidaxomicin for prevention of CDAD in HSCT patients. METHODS ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr · January 2019
OBJECTIVE: To assess whether length of hospital stay is decreased among moderately preterm infants weaned from incubator to crib at a lower vs higher weight. STUDY DESIGN: This trial was conducted in the Eunice Kennedy Shriver National Institute of Child H ...
Full textLink to itemCite
Journal ArticleEur J Clin Microbiol Infect Dis · January 2019
Infections are among the top three causes of death of older adults in the first year after kidney transplantation (KT). Our aim was to describe infectious complications among KT recipients aged ≥ 65 during the first 12 months post-transplant. Single-center ...
Full textLink to itemCite
Chapter · January 1, 2019
In organ transplant recipients, impaired inflammatory responses suppress the clinical and radiologic findings of infection. The possible etiologies of infection are diverse, ranging from common bacterial and viral pathogens that affect the entire community ...
Full textCite
Journal ArticleTranspl Infect Dis · October 2018
Invasive mold disease in thoracic organ transplant recipients is a well-recognized complication, but the long-term persistence of molds within the human body and evasion of host defenses has not been well-described. We present 2 cases of invasive mold dise ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · June 2018
BACKGROUND: Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy. METHODS: Ninety-two AL p ...
Full textOpen AccessLink to itemCite
Journal ArticlePediatrics · May 2018
OBJECTIVES: Evaluate the spectrum of neurodevelopmental outcome in a contemporary cohort of extremely preterm infants. We hypothesize that the rate of severe neurodevelopmental impairment (NDI) decreases over time. METHODS: Retrospective analysis of neurod ...
Full textLink to itemCite
Journal ArticleJ Pediatr · April 2018
OBJECTIVE: To determine the outcome of preterm infants whose cystic periventricular leukomalacia "disappeared" on serial screening cranial imaging studies. STUDY DESIGN: Infants ≤26 weeks of gestation born between 2002 and 2012 who had cranial imaging stud ...
Full textLink to itemCite
Journal ArticleJ Pediatr · April 2018
OBJECTIVES: To describe the frequency and findings of cranial imaging in moderately preterm infants (born at 290/7-336/7 weeks of gestation) across centers, and to examine the association between abnormal imaging and clinical characteristics. STUDY DESIGN: ...
Full textLink to itemCite
Journal ArticleJ Pediatr · April 2018
OBJECTIVES: To describe the frequency and extent of delivery room resuscitation and evaluate the association of delivery room resuscitation with neonatal outcomes in moderately preterm (MPT) infants. STUDY DESIGN: This was an observational cohort study of ...
Full textLink to itemCite
Journal ArticleJ Pediatr · January 2018
OBJECTIVE: To evaluate the temperature distribution among moderately preterm (MPT, 29-33 weeks) and extremely preterm (EPT, <29 weeks) infants upon neonatal intensive care unit (NICU) admission in 2012-2013, the change in admission temperature distribution ...
Full textLink to itemCite
Journal ArticleJAMA Pediatr · January 1, 2018
IMPORTANCE: Studies of cranial ultrasonography and early childhood outcomes among cohorts of extremely preterm neonates have linked periventricular-intraventricular hemorrhage and cystic periventricular leukomalacia with adverse neurodevelopmental outcomes ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · November 2017
SCY-078 in vitro activity was determined for 178 isolates of resistant or susceptible Candida albicans, Candida dubliniensis, Candida glabrata, Candida krusei, Candida lusitaniae, and Candida parapsilosis, including 44 Candida isolates with known genotypic ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 1, 2017
Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough wi ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · May 2017
Breakpoints are used to predict whether an antifungal agent will be clinically effective against a particular fungal isolate. They are based on a combination of MIC values, pharmacokinetic/pharmacodynamic values, and clinical outcome data. For many fungus- ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 1, 2017
BACKGROUND: Nontuberculous mycobacteria (NTM) commonly colonize municipal water supplies and cause healthcare-associated outbreaks. We investigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital. METHODS: Case patients had recen ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · March 2017
The in vitro activities of fungal CYP51 inhibitors VT-1161 and VT-1129 were determined for Candida glabrata (n = 34) and C. krusei (n = 50). C. glabrata isolates were screened for FKS gene mutations. All isolates were resistant clinically and/or in vitro t ...
Full textLink to itemCite
Journal ArticleAm J Transplant · January 2017
Interstitial nephritis due to viruses is well-described after solid organ transplantation. Viruses implicated include cytomegalovirus; BK polyomavirus; Epstein-Barr virus; and, less commonly, adenovirus. We describe a rare case of hemorrhagic allograft nep ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · 2017
BACKGROUND: Phaeohyphomycosis is infection caused by dematiaceous, or darkly pigmented, fungi. The spectrum of disease is broad, and optimal therapy remains poorly defined. The Mycoses Study Group established an international case registry of patients with ...
Full textOpen AccessLink to itemCite
Journal ArticleTranspl Infect Dis · December 2016
BACKGROUND: Invasive candidiasis (IC) is a common cause of mortality in solid organ transplant recipients (OTRs), but knowledge of epidemiology in this population is limited. METHOD: The present analysis describes data from 15 US centers that prospectively ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2016
We report the case of a 60-year-old man with septic shock due to Capnocytophaga canimorsus that was diagnosed in 24 hours by a novel whole-genome next-generation sequencing assay. This technology shows great promise in identifying fastidious pathogens, and ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr · August 2016
OBJECTIVE: To estimate risk of necrotizing enterocolitis (NEC) for extremely low birth weight (ELBW) infants as a function of preterm formula (PF) and maternal milk intake and calculate the impact of suboptimal feeding on the incidence and costs of NEC. ST ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 2016
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeut ...
Full textLink to itemCite
Journal ArticleNat Commun · March 29, 2016
The fungal pathogen Candida glabrata has emerged as a major health threat since it readily acquires resistance to multiple drug classes, including triazoles and/or echinocandins. Thus far, cellular mechanisms promoting the emergence of resistance to multip ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Transl Med · January 20, 2016
Systemic Candida albicans infection causes high morbidity and mortality and is now the leading cause of nosocomial bloodstream infection in the United States. Neutropenia is a major risk factor for poor outcome in infected patients; however, the molecular ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · October 2015
Invasive mold infections are life-threatening diseases for which appropriate antifungal therapy is crucial. Their epidemiology is evolving, with the emergence of triazole-resistant Aspergillus spp. and multidrug-resistant non-Aspergillus molds. Despite the ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · July 2015
The limited armamentarium of active and oral antifungal drugs against emerging non-Aspergillus molds is of particular concern. Current antifungal agents and the new orally available beta-1,3-d-glucan synthase inhibitor SCY-078 were tested in vitro against ...
Full textLink to itemCite
Journal ArticleMed Mycol · June 2015
Transplant recipients are at a high risk for developing invasive fungal infections. The agents of phaeohyphomycosis are environmental molds found worldwide, and they cause a broad spectrum of disease including skin and subcutaneous lesions, pneumonia, cent ...
Full textLink to itemCite
Journal ArticleJ Antimicrob Chemother · May 2015
OBJECTIVES: Invasive mould infections are associated with a high mortality rate and the emergence of MDR moulds is of particular concern. Calcineurin and its chaperone, the heat shock protein 90 (Hsp90), represent an important pathway for fungal virulence ...
Full textLink to itemCite
Journal ArticleN Engl J Med · January 22, 2015
BACKGROUND: Understanding the causes and timing of death in extremely premature infants may guide research efforts and inform the counseling of families. METHODS: We analyzed prospectively collected data on 6075 deaths among 22,248 live births, with gestat ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 1, 2015
BACKGROUND: Risk factors including how changes in immunosuppression influence the occurrence of immune reconstitution syndrome (IRS) in solid organ transplant (SOT) recipients with cryptococcosis have not been fully defined. METHODS: SOT recipients with cr ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
Invasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections acc ...
Full textOpen AccessLink to itemCite
Journal ArticleTranspl Infect Dis · October 2014
Hepatitis B virus (HBV) core antibody (HBcAb)-positive donors are increasingly utilized in solid organ transplantation. We report a single center's experience in cardiac transplantation with 18 HBcAb-positive donors. Available follow-up on recipients of ca ...
Full textLink to itemCite
Journal ArticleMed Mycol · July 2014
Paecilomyces species are emerging fungal pathogens. Morphological identifications are complicated by similarities among the members of the P. variotii complex as well as to some Rasamsonia and Hamigera species. The purpose of this study was to compare matr ...
Full textLink to itemCite
Journal ArticleClin Lab Med · June 2014
Diagnosis of invasive fungal pneumonias by conventional culture methods is difficult to assess and often delayed. Nonmolecular fungal markers have emerged as an important adjunctive tool to support their diagnosis in combination with other clinical, radiol ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2014
Invasive mold infections (IMIs) are a major source of morbidity and mortality among lung transplant recipients (LTRs), yet information regarding the epidemiology of IMI in this population is limited. From 2001 to 2006, multicenter prospective surveillance ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 2014
Research to develop and validate novel methods for diagnosis of aspergillosis based on detection of galactomannan requires the use of clinical specimens that have been stored frozen. Data indicating that galactomannan remains stable when frozen are scant. ...
Full textLink to itemCite
Journal ArticleMed Mycol · May 2014
Candida albicans can cause candidemia in neutropenic and critically ill patients and oropharyngeal candidiasis in human immunodeficiency virus (HIV)-positive patients with low CD4(+) counts. Because all patients at risk do not develop Candida infections, i ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · April 2014
BACKGROUND: Invasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on the epidemiology of endemic fungal infections in t ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · December 2013
Systemic Candida albicans infection causes high morbidity and mortality and is associated with neutropenia; however, the roles of other innate immune cells in pathogenesis are poorly defined. Here, using a mouse model of systemic candidiasis, we found that ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · July 2013
Twelve laboratories evaluated candidate material for an Aspergillus DNA calibrator. The DNA material was quantified using limiting-dilution analysis; the mean concentration was determined to be 1.73 × 10(10) units/ml. The calibrator can be used to standard ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 2013
BACKGROUND: Fluconazole (FLC) resistance is common in C. glabrata and echinocandins are often used as first-line therapy. Resistance to echinocandin therapy has been associated with FKS1 and FKS2 gene alterations. METHODS: We reviewed records of all patien ...
Full textLink to itemCite
Journal ArticleClin Transplant · 2013
BK polyomavirus (BKV) infection continues to be a significant source of allograft dysfunction in kidney transplant recipients. The optimal screening method to detect BKV remains undetermined. In this retrospective analysis of 347 consecutive kidney transpl ...
Full textLink to itemCite
Journal ArticlePharmacotherapy · October 2012
STUDY OBJECTIVE: To determine the true institutional cost of treating invasive fungal infections in light of recent advances in diagnostic techniques and antifungal therapies for both treatment and prophylaxis of these infections. DESIGN: Economic analysis ...
Full textLink to itemCite
Journal ArticleEur J Clin Microbiol Infect Dis · September 2012
Species of Candida frequently cause life-threatening infections in neonates, transplant and intensive care unit (ICU) patients, and others with compromised host defenses. The successful management of systemic candidiasis depends upon early, rapid diagnosis ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Infect Dis · March 15, 2012
BACKGROUND: Candidemia is a severe invasive fungal infection with high mortality. Recognition of Candida species is mediated through pattern recognition receptors such as Toll-like receptors (TLRs). This study assessed whether genetic variation in TLR sign ...
Full textLink to itemCite
Journal ArticleEur J Clin Microbiol Infect Dis · March 2012
Candida is one of the leading causes of sepsis, and an effective host immune response to Candida critically depends on the cytokines IL-1β and IL-18, which need caspase-1 cleavage to become bioactive. Caspase-12 has been suggested to inhibit caspase-1 acti ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · February 15, 2012
BACKGROUND: Candida bloodstream infections cause significant morbidity and mortality among hospitalized patients. Although clinical and microbiological factors affecting prognosis have been identified, the impact of genetic variation in the innate immune ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS One · 2012
BACKGROUND: Invasive candidiasis (IC) is a devastating disease. While prompt antifungal therapy improves outcomes, empiric treatment based on the presence of fever has little clinical impact. Β-D-Glucan (BDG) is a fungal cell wall component detectable in t ...
Full textOpen AccessLink to itemCite
Journal ArticleSemin Respir Crit Care Med · December 2011
Fungal pneumonia is increasingly common, particularly in highly immunosuppressed patients, such as solid organ or hematopoietic stem cell transplant recipients, and the diagnosis is evolving. Although standard techniques such as microscopy and culture rema ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · October 2011
Recent reports describe increasing incidence of non-Aspergillus mold infections in hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients. To investigate the epidemiology of infections with Mucorales, Fusarium spp., and Scedosporiu ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Infect Dis · October 1, 2011
BACKGROUND: Candidemia is an important cause of morbidity and mortality in critically ill patients or patients undergoing invasive treatments. Dectin-1 is the main β-glucan receptor, and patients with a complete deficiency of either dectin-1 or its adaptor ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · August 2011
One potential limitation of DNA-based molecular diagnostic tests for Candida bloodstream infection (BSI) is organism burden, which is not sufficiently characterized. We hypothesized that the number of CFU per milliliter (CFU/ml) present in an episode of Ca ...
Full textLink to itemCite
Journal ArticleDiagn Microbiol Infect Dis · July 2011
We reassessed the Clinical and Laboratory Standards Institute (CLSI) clinical breakpoints (CBPs) for voriconazole. We examined i) the essential (EA: ±2 dilutions) and categorical agreement between 24-h CLSI and EUCAST methods for voriconazole testing of Ca ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · May 2011
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection. Microscopic diagnosis, including diagnosis using the Merifluor-Pneumocystis direct fluorescent antigen (MP-DFA) test, has limitations. Real-time PCR may assist in diagnosis, but no ...
Full textLink to itemCite
Journal ArticleHematol Oncol Clin North Am · February 2011
Recent shifts in the epidemiology of invasive fungal infections (IFIs) among transplant and oncology populations have led to new recommendations on treatment; however, they have also brought new controversies. New pharmacologic therapies are being studied ...
Full textLink to itemCite
Chapter · January 1, 2011
Phaeohyphomycosis, a term first introduced by Ajello and colleagues [1], is an encompassing clinical designation for a spectrum of infections caused by darkly pigmented moulds [2, 3]. In its simplest definition, phaeohyphomycosis is an infection caused by ...
Full textCite
Journal ArticleEmerging Infectious Diseases · January 1, 2011
Recent reports describe increasing incidence of non- Aspergillus mold infections in hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients. To investigate the epidemiology of infections with Mucorales, Fusarium spp., and Scedospori ...
Full textCite
Journal ArticlePharmacotherapy · January 2011
STUDY OBJECTIVES: To determine the optimal nebulization system for aerosolizing micafungin and to further assess the physiochemical properties of aerosolized micafungin. DESIGN: In vitro experiment. SETTING: University research center. NEBULIZERS: Pari LC ...
Full textLink to itemCite
Journal ArticlePharm Dev Technol · 2011
Pharmaceutical aerosols have the potential to prevent pulmonary infectious diseases. Liposomal amphotericin B (LAMB, Ambisome, Astellas Pharma US, Deerfield, IL, USA) is approved as an intravenous infusion for empiric treatment of presumed fungal infection ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · November 2010
The Fungitell assay for (1,3)β-D-glucan (BG) detection in serum has been evaluated in patients with invasive fungal infections (IFIs) and healthy controls and for the early diagnosis of IFI in cancer patients. We evaluated the BG assay for the detection of ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · November 1, 2010
BACKGROUND: Cryptococcosis occurring ≤30 days after transplantation is an unusual event, and its characteristics are not known. METHODS: Patients included 175 solid-organ transplant (SOT) recipients with cryptococcosis in a multicenter cohort. Very early-o ...
Full textOpen AccessLink to itemCite
Journal ArticleMed Mycol · September 2010
Clinical manifestations, treatment, and outcomes of cutaneous cryptococcosis in solid organ transplant (SOT) recipients are not fully defined. In a prospective cohort comprising 146 SOT recipients with cryptococcosis, we describe the presentation, antifung ...
Full textLink to itemCite
Journal ArticleAm J Transplant · September 2010
Two patients developed renal mucormycosis following transplantation of kidneys from the same donor, a near-drowning victim in a motor vehicle crash. Genotypically, indistinguishable strains of Apophysomyces elegans were recovered from both recipients. We i ...
Full textLink to itemCite
Journal ArticleDiagn Microbiol Infect Dis · August 2010
Fungal polymerase chain reaction (PCR)-based diagnostic methods are at risk for contamination. Sample collection containers were investigated for fungal DNA contamination using real-time PCR assays. Up to 18% of blood collection tubes were contaminated wit ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · July 2010
For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through >or=3 doses of micafungin therapy during th ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 15, 2010
BACKGROUND: Invasive aspergillosis (IA) is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients. The purpose of this study was to evaluate factors associated with mortality i ...
Full textOpen AccessLink to itemCite
Journal ArticleInfect Dis Clin North Am · June 2010
Recent shifts in the epidemiology of invasive fungal infections (IFIs) among transplant and oncology populations have led to new recommendations on treatment; however, they have also brought new controversies. New pharmacologic therapies are being studied ...
Full textLink to itemCite
Journal ArticleDiagn Microbiol Infect Dis · May 2010
Rapid, accurate diagnosis of community-acquired pneumonia (CAP) due to Mycoplasma pneumoniae is compromised by low sensitivity of culture and serology. Polymerase chain reaction (PCR) has emerged as a sensitive method to detect M. pneumoniae DNA in clinica ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · April 15, 2010
BACKGROUND: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and secular trends are lacking. METHODS: The Transplant-Asso ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · April 15, 2010
BACKGROUND: The incidence and epidemiology of invasive fungal infections (IFIs), a leading cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived mainly from single-institution retrospective studies. METHODS: The Transplant ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Perinatol · April 2010
OBJECTIVE: Our aim was to determine the incidence of anatomical abnormalities after a urinary tract infection (UTI) in infants <2 months of age hospitalized in the neonatal intensive care unit (NICU). STUDY DESIGN: This was a retrospective, single-center c ...
Full textOpen AccessLink to itemCite
Journal ArticleTransplantation · January 15, 2010
BACKGROUND: Cerebrospinal fluid (CSF) analysis is often deferred in patients with cryptococcal disease, particularly in the absence of neurologic manifestations. We sought to determine whether a subset of solid organ transplant (SOT) recipients with high l ...
Full textLink to itemCite
Journal ArticleAnn Transplant · 2010
BACKGROUND: Whether there are geographic differences in clinical presentation of cryptococcosis in solid organ transplant (SOT) recipients in the United States (US) is not known. MATERIAL/METHODS: Patients comprised a cohort of 120 SOT recipients from US t ...
Link to itemCite
Journal ArticleClin Infect Dis · December 1, 2009
BACKGROUND: Whether outcome of central nervous system (CNS) cryptococcosis in solid organ transplant recipients treated with lipid formulations of amphotericin B is different from the outcome of the condition treated with amphotericin B deoxycholate (AmBd) ...
Full textLink to itemCite
Journal ArticleCurr Infect Dis Rep · November 2009
Solid organ transplantation is emerging as a lifesaving procedure for increasing numbers of patients, and invasive fungal infections are a significant cause of mortality and morbidity for patients undergoing such procedures. Risks for developing these infe ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · October 2009
Antifungal susceptibility testing of Aspergillus species has been standardized by both the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Recent studies suggest the emergence ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · October 2009
A large aggregate collection of clinical isolates of aspergilli (n = 218) from transplant patients with proven or probable invasive aspergillosis was available from the Transplant-Associated Infection Surveillance Network, a 6-year prospective surveillance ...
Full textLink to itemCite
Journal ArticleAAPS PharmSciTech · 2009
Pharmaceutical aerosols have been targeted to the lungs for the treatment of asthma and pulmonary infectious diseases successfully. Micafungin (Astellas Pharma US, Deerfield, IL, USA) has been shown to be an effective antifungal agent when administrated in ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · November 2008
We investigated if CLSI M27-A2 Candida species breakpoints for fluconazole MIC are valid when read at 24 h. Analysis of a data set showed good correlation between 48- and 24-h MICs, as well as similar outcomes and pharmacodynamic efficacy parameters, excep ...
Full textLink to itemCite
Journal ArticleTransplantation · September 27, 2008
BACKGROUND: The incidence of invasive fungal infections (IFIs) in solid organ transplant (SOT) recipients has increased during the past 20 years and is associated with significant morbidity and mortality. In this post hoc analysis of a large, open-label, m ...
Full textLink to itemCite
Journal ArticleTransplantation · September 15, 2008
BACKGROUND: Prognostic implications of cryptococcal antigen and outcomes associated with central nervous system (CNS) cryptococcal lesions in solid organ transplant recipients have not been fully defined. METHODS: Patients were derived form a cohort of 122 ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · August 2008
The CLSI Antifungal Subcommittee followed the M23-A2 "blueprint" to develop interpretive MIC breakpoints for anidulafungin, caspofungin, and micafungin against Candida species. MICs of < or = 2 microg/ml for all three echinocandins encompass 98.8 to 100% o ...
Full textLink to itemCite
Journal ArticleAm J Transplant · May 2008
Within the Burkholderia cepacia complex (Bcc), B. cenocepacia portends increased mortality compared with other species. We investigated the impact of Bcc infection on mortality and re-infection following lung transplant (LT). Species designation for isolat ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · February 2008
Synergistic interactions were observed between CIs and antifungal agents against 53 (90%) of 59 Cryptococcus neoformans isolates from solid organ transplant recipients with cryptococcosis and may account for better outcomes in patients with cryptococcosis ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 15, 2008
BACKGROUND: The role of serum cryptococcal antigen in the diagnosis and determinants of antigen positivity in solid organ transplant (SOT) recipients with pulmonary cryptococcosis has not been fully defined. METHODS: We conducted a prospective, multicenter ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · January 2008
We evaluated the performance of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method, a rapid two-color assay for detection of C. albicans and C. glabrata, in a multicenter study. The assay is desig ...
Full textLink to itemCite
Journal ArticlePediatr Infect Dis J · December 2007
We compared outcomes in infants with methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Infants with methicillin-resistant S. aureus infection had a longer median duration of bacteremia (4.5 versus 1 day, P = 0.01), but no di ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · December 2007
Clostridium difficile-associated diarrhea (CDAD) has a wide spectrum of disease severity. Studies have implicated immunosuppressants as a risk factor for severe disease. We hypothesized that solid organ transplant (SOT) patients with CDAD would be at great ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · August 2007
BACKGROUND: The Burkholderia cepacia complex is associated with colonization or disease in patients with cystic fibrosis (CF). For patients without CF, this complex is poorly understood apart from its presence in occasional point source outbreaks. OBJECTIV ...
Full textLink to itemCite
Journal ArticlePediatr Infect Dis J · July 2007
BACKGROUND: The galactomannan (GM) assay is an approved noninvasive test for detection of invasive aspergillosis (IA) that has been validated in adult patients with hematologic malignancies who are undergoing bone marrow transplantation. There have been fe ...
Full textLink to itemCite
Journal ArticleClin Vaccine Immunol · July 2007
1,3-Beta-D-Glucan serum levels have demonstrated good diagnostic sensitivity and specificity for the diagnosis of candidiasis in adult patients, but normal levels for children have not been established. We found higher 1,3-beta-D-glucan levels in children ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 2007
The Digene Hybrid Capture system cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests were compared using whole-virus standards and plasma specimens collected from allogeneic ...
Full textLink to itemCite
Journal ArticleEur J Clin Microbiol Infect Dis · April 2007
The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at l ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · March 2007
Most patients with herpes simplex virus (HSV) central nervous system (CNS) infection have abnormal cerebrospinal fluid (CSF) indices. Therefore, we implemented screening criteria based on CSF values and host immune status to guide testing. All CSF samples ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · March 1, 2007
Variables influencing the risk of dissemination and outcome of Cryptococcus neoformans infection were assessed in 111 organ transplant recipients with cryptococcosis in a prospective, multicenter, international study. Sixty-one percent (68/111) of the pati ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · March 2007
To assess their utility for antifungal susceptibility testing in our clinical laboratory, the Etest and Sensititre methods were compared with the Clinical and Laboratory Standards Institute (CLSI) M27-A2 reference broth microdilution method. Fluconazole (F ...
Full textLink to itemCite
Journal ArticleJ Perinatol · February 2007
OBJECTIVE: The purpose of this study was to examine the frequency of normal cerebrospinal fluid (CSF) parameters in Candida meningitis and the proportion of candidemia associated with Candida meningitis. STUDY DESIGN: We evaluated the initial lumbar punctu ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · February 2007
An 8-month-old boy developed a necrotic lung mass from which Burkholderia glumae was recovered, leading to the diagnosis of chronic granulomatous disease (CGD). While other Burkholderia species have been identified as important pathogens in persons with CG ...
Full textLink to itemCite
Journal ArticleAm J Med · November 2006
BACKGROUND: Caspofungin is emerging as first-line therapy for invasive candidiasis. Data on the use of caspofungin for treatment for invasive candidiasis are limited to clinical trials and case reports. We report a single-center experience with 104 consecu ...
Full textLink to itemCite
Journal ArticleExpert Rev Anti Infect Ther · October 2006
Infection is a frequent complication of organ transplantation and is associated with significant morbidity and mortality. Preventative antimicrobial strategies are a key component of the care received by transplant patients. This review summarizes the evid ...
Full textLink to itemCite
Journal ArticleClinical Infectious Diseases · August 1, 2006
Invasive fungal infections have become a major cause of morbidity and mortality over the past 3 decades. Organ transplantation, the use of aggressive chemotherapy, and the availability and widespread use of immunosuppressive treatments for many medical ail ...
Full textCite
Journal ArticleDiagn Microbiol Infect Dis · April 2006
Antifungal expenditures are substantial for many hospitals. Using caspofungin for the treatment of candidemia accounts for a sizable proportion of the costs. A cost minimization study that used a decision analytic model was done to compare in-hospital diag ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · March 2006
Allogeneic hematopoietic stem cell transplant (HSCT) recipients are at increased risk for invasive fungal infections (IFIs) over prolonged periods of time. Aerosolized amphotericin B lipid complex (ABLC) has shown promise in lung transplant recipients as a ...
Full textLink to itemCite
Journal ArticleClin Chest Med · December 2005
Although species of Aspergillus and Candida account for most deeply invasive and life-threatening fungal infections, the past decades have seen a rise in the immunocompromised population. With this increase, additional fungi have emerged as important agent ...
Full textLink to itemCite
Journal ArticleCurrent Opinion in Organ Transplantation · December 1, 2005
Purpose of review: Invasive fungal infections remain a predominant cause of morbidity and mortality in the immunocompromised population. Fungal diagnostics, namely the Platelia Aspergillus enzyme immunoassay (Bio-Rad, Redmond, WA) and the Fungitell 1→-β-D- ...
Full textCite
Journal ArticleTransplantation · October 27, 2005
This study describes the association of allograft loss and immune reconstitution syndrome (IRS) in the course of Cryptococcosis neoformans infection in renal transplant recipients. Patients comprised 54 renal allograft recipients with cryptococcosis in a p ...
Full textLink to itemCite
Journal ArticleTransplantation · October 27, 2005
BACKGROUND: Therapeutic practices for Cryptococcus neoformans infection in transplant recipients vary, particularly with regards to antifungal agent employed, and duration of therapy. The risk of relapse and time to recurrence is not known. We assessed ant ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · October 15, 2005
In this study of 263 heart, kidney, liver, and pancreas transplant patients, BK virus (BKV) and JC virus (JCV) DNAemia were observed most commonly in kidney and/or pancreas transplant patients (26%), although they were also observed, to a lesser extent, in ...
Full textLink to itemCite
ConferenceJ Infect Dis · October 15, 2005
The epidemiology of infections with 5 human herpesviruses (HHVs) (HHV-6, HHV-7, HHV-8, varicella zoster virus [VZV], and Epstein-Barr virus [EBV]) was investigated during the first year after solid organ transplantation in 263 patients who received oral ga ...
Full textLink to itemCite
Journal ArticleTransplantation · September 27, 2005
The clinical impact of voriconazole resistance in Candida glabrata is not well described. Five hematopoietic stem cell transplant recipients that developed breakthrough Candida glabrata bloodstream infections while receiving voriconazole are described and ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 1, 2005
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · September 2005
The Platelia galactomannan enzyme immunoassay is a commercially available nonculture method for diagnosing invasive aspergillosis. Recently, steps have been taken to improve sensitivity; specifically, a low (0.5 to 0.7) galactomannan index (GMI) value to d ...
Full textLink to itemCite
Journal ArticleExpert Opin Pharmacother · August 2005
Novel therapies to treat invasive fungal infections have revolutionised the care of patients with candidiasis, aspergillosis and other less common fungal infections. Physicians in the twenty first century have access to safer versions of conventional drugs ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 15, 2005
BACKGROUND: We describe an immune reconstitution syndrome (IRS)-like entity in the course of evolution of Cryptococcus neoformans infection in organ transplant recipients. METHODS: The study population comprised a cohort of 83 consecutive organ transplant ...
Full textLink to itemCite
Journal ArticleTransplantation · June 15, 2005
BACKGROUND: A randomized, double-blind study was conducted to evaluate the pharmacokinetics of ganciclovir following oral administration of ganciclovir or valganciclovir for prophylaxis of cytomegalovirus (CMV) disease in solid organ transplant recipients ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 2005
We evaluated aliquots from 244 clinical blood culture bottles that demonstrated yeasts on Gram stain using a Candida albicans peptide nucleic acid (PNA) fluorescent in situ hybridization (FISH) probe. The sensitivity, specificity, positive predictive value ...
Full textLink to itemCite
Journal ArticleDrugs Today (Barc) · June 2005
Invasive fungal infections are occurring with increasing frequency secondary to medical advances in the areas of transplantation, cancer management and autoimmune diseases. Unfortunately, the currently available antifungal armamentarium does not meet the i ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · May 1, 2005
To investigate the renal safety of amphotericin B lipid complex (ABLC), records from 3514 ABLC-treated patients with fungal infections were reviewed. The median change in predicted creatinine clearance (CCr) from baseline to the end of therapy was -3 mL/mi ...
Full textLink to itemCite
Journal ArticleJ Phys Chem B · March 3, 2005
Surface-enhanced resonance Raman scattering (SERRS) from the alpha-diimine complexes [Ru(bpm)(3)](2+) and [Ru(bpz)(3)](2+) is reported for the first time at a roughened silver electrode. In both cases, a possible adsorbate orientation has been proposed inv ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 1, 2005
BACKGROUND: Unique characteristics, impact of therapy with antifungal agents, and outcome of infections with Scedosporium species were assessed in transplant recipients. METHODS: The patients comprised a total of 80 transplant recipients with Scedosporium ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · January 2005
The immunosuppressants tacrolimus (FK506) and cyclosporine A inhibit calcineurin and have potent antifungal activity. In this study, 24% of Cryptococcus neoformans isolates from solid-organ transplant patients exhibited altered sensitivity to these drugs, ...
Full textLink to itemCite
Journal ArticleClin Pharmacokinet · 2005
BACKGROUND: Valganciclovir (Valcyte) has recently been approved for the prevention of cytomegalovirus (CMV) disease in high-risk (CMV donor positive [D+]/recipient negative [R-]) solid organ transplant (SOT) recipients. Large-scale studies describing the p ...
Full textLink to itemCite
Journal ArticleTransplantation · December 27, 2004
BACKGROUND: Cytomegalovirus (CMV) D+/R- solid-organ transplant (SOT) recipients carry increased risk of developing CMV disease; however, other risk factors in these patients have not been delineated. METHODS: We examined 20 demographic and clinical variabl ...
Full textLink to itemCite
Journal ArticleRespir Care Clin N Am · December 2004
Infections remain a serious and common problem in lung transplant recipients. Recent years have seen an explosion in the knowledge regarding this major cause of morbidity and mortality. Novel diagnostic and therapeutic techniques are revolutionizing the ap ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · May 1, 2004
The Burkholderia cepacia complex includes 9 genomovars. The relative virulence of each is unknown. Host and pathogen features associated with mortality were evaluated among patients with B. cepacia complex bacteremia. Cases were ascertained through review ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · May 1, 2004
We investigated the emergence of cytomegalovirus (CMV) ganciclovir-resistance mutations in 301 high-risk solid-organ transplant (SOT) recipients after oral prophylaxis, for 100 days, with either valganciclovir or ganciclovir. For patients treated with ganc ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2004
Despite prophylaxis, cytomegalovirus (CMV) disease is common in donor seropositive (D+)/recipient seronegative (R-) transplant patients after cessation of prophylaxis. Early detection of CMV may allow for pre-emptive therapy to prevent active disease. The ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2004
We compared the efficacy and safety of valganciclovir with those of oral ganciclovir in preventing cytomegalovirus (CMV) disease in high-risk seronegative solid organ transplant (SOT) recipients of organs from seropositive donors (D+/R-). In this randomise ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · March 2004
A 64-year-old male with Aspergillus fumigatus infection that had disseminated from the lung to the ankle and adjacent bone was treated successfully with posaconazole after therapy with itraconazole and amphotericin B lipid complex failed. Marked clinical i ...
Full textLink to itemCite
Journal ArticleInorg Chem · January 12, 2004
For the first time, a full scaled quantum chemical normal coordinate analysis has been performed on [Ru(LL')(3)](2+) complexes, where LL' = 2,2'-bipyrazine (bpz) or 2,2'-bipyrimidine (bpm). Geometric structures were fully optimized using density functional ...
Full textLink to itemCite
Journal ArticleJ Am Acad Dermatol · August 2003
Serratia sp have only rarely been reported as isolates from leg ulcers. We describe the case of a middle-aged man with a medical history significant for alcohol-induced cirrhosis who presented with rapidly progressive skin ulcers initially starting as purp ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · July 15, 2003
To determine the spectrum and impact of mycelial fungal infections, particularly those due to non-Aspergillus molds, 53 liver and heart transplant recipients with invasive mycelial infections were prospectively identified in a multicenter study. Invasive m ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · May 2003
A 30-year-old man died with Pandoraea pnomenusa sepsis after lung transplantation. Pandoraea species are gram-negative rods, closely related to, and commonly misidentified as, Burkholderia cepacia complex or Ralstonia species. Heretofore considered soil ba ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 1, 2003
To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as "the earlier cohort") were compared with 2 ...
Full textLink to itemCite
Journal ArticleCurr Opin Infect Dis · December 2002
PURPOSE OF REVIEW: Solid organ transplantation is emerging as a life-saving procedure for increasing numbers of patients and invasive fungal infections are a significant cause of mortality and morbidity for patients undergoing these procedures. This paper ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · 2002
The dramatic increase in nosocomial invasive mycoses over the past two decades has led to increased interest in the area of antifungal development. Unfortunately, the infusion of new diagnostic technology into the clinical mycology laboratory has lagged be ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · November 2001
We prospectively assessed the management of patients with suspected tuberculosis (TB) in an area with a high prevalence of nontuberculous mycobacteria (NTM) and a low incidence of TB. Clinicians' assessments were sensitive for TB but had poor predictive va ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · September 2001
Lung transplantation is associated with a high incidence of infection which directly impacts the morbidity and mortality associated with the procedure. In addition, these infections may also have immunologic consequences that play a role in the evolution o ...
Full textLink to itemCite
Journal ArticleAm J Kidney Dis · April 2001
Viral infections are a leading cause of posttransplantation morbidity and mortality. A number of recent developments have altered our understanding and management of these disorders. The pathogenetic roles of several viruses, including human herpesviruses ...
Full textLink to itemCite
Journal ArticleTransplantation · June 15, 2000
BACKGROUND: Although infection is a leading cause of death after lung transplantation, very little is known about the incidence, epidemiology, and clinical significance of bloodstream infections in lung transplant recipients. METHODS: All blood cultures we ...
Full textLink to itemCite
Journal ArticleMed Mycol · 2000
The incidence of invasive fungal infection (IFI) has increased considerably over the past 20 years, and transplant recipients are at especially high risk for fungal infections owing to their overall immunosuppressed condition. Organ transplantation procedu ...
Link to itemCite
Journal ArticleDrugs · November 1997
Medical advances have led to increased numbers of immunocompromised patients living longer. Coinciding with this increase in the immunocompromised patient population is an increase in the number of clinically significant fungal infections. Unfortunately, w ...
Full textLink to itemCite